Publications by authors named "A Reshef"

Claim this Profile
G
Garadacimab in hereditary angioedema due to normal C1INH with F12/PLG mutations.
Danny M Cohn, Avner Reshef, Petra Staubach, William R Lumry, Henrike Feuersenger

J Allergy Clin Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes of colorectal cancer in elderly patients, insights from a large database in Israel.
Naim Abu-Freha, Ahab Hayadri, Noor Sanalla, Roba Ganayem, Braa Abu-Ganim, Avraham Reshef

Eur J Cancer Prev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema: APeX-S final results.
Henriette Farkas, Jonny G Peter, Marcin Stobiecki, John Anderson, Emel Aygören-Pürsün, Avner Reshef

Ann Allergy Asthma Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Garadacimab improves long-term health-related quality of life in patients with hereditary angioedema.
Mar Guilarte, William R Lumry, Markus Magerl, Inmaculada Martinez Saguer, Avner Reshef

Allergy Asthma Proc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment.
Bruce L Zuraw, Konrad Bork, Laurence Bouillet, Sandra C Christiansen, Henriette Farkas, Avner Reshef

Clin Rev Allergy Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis